Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma

Figure 1

Schematic view of the MAPK and PI3K pathways. Drugs targeting the multiple kinases in the signaling cascades are represented in blue.